OPGN
CapForce Inc
Price Chart
No historical data available
Latest Quote
$24.75
+0.00 (+0.00%)
Current Price
| Previous Close | $24.75 |
| Open | $22.05 |
| Day High | $31.00 |
| Day Low | $17.00 |
| Volume | 1,999 |
Stock Information
| Shares Outstanding | 10.15M |
| Total Debt | $1.89M |
| Cash Equivalents | $414K |
| Revenue | $9.00M |
| Net Income | $6.71M |
| Sector | Financial Services |
| Industry | Capital Markets |
| Market Cap | $251.20M |
| P/E Ratio | 137.50 |
| EPS (TTM) | $0.18 |
| Exchange | PNK |
Recent Price History
No history data available. Data will be fetched automatically.
About CapForce Inc
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company's products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $33,211 | $3,509,014 | $3,423,991 | $2,848,448 |
| Cost Of Revenue | $33,211 | $3,509,014 | $3,423,991 | $2,848,448 |
| Total Revenue | $5,196,149 | $3,418,320 | $2,607,293 | $4,306,031 |
| Operating Revenue | $5,196,149 | $3,418,320 | $2,607,293 | $4,306,031 |
| Expenses | ||||
| Interest Expense | $7,555 | $1,838,933 | $3,256,410 | $4,799,331 |
| Total Expenses | $4,796,294 | $19,106,797 | $24,826,166 | $27,408,353 |
| Other Income Expense | $11,405,698 | $-15,283,608 | $-11,854,885 | $-6,905,410 |
| Other Non Operating Income Expenses | $-908,586 | - | - | - |
| Net Non Operating Interest Income Expense | $363,889 | $-1,696,445 | $-3,209,475 | $-4,754,152 |
| Interest Expense Non Operating | $7,555 | $1,838,933 | $3,256,410 | $4,799,331 |
| Operating Expense | $4,763,083 | $15,597,783 | $21,402,175 | $24,559,905 |
| Selling And Marketing Expense | $172,238 | $2,783,268 | $4,344,656 | $3,713,263 |
| General And Administrative Expense | $4,542,025 | $8,081,664 | $8,884,084 | $9,935,963 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $11,992,780 | $-32,668,530 | $-37,283,233 | $-34,805,712 |
| Net Interest Income | $363,889 | $-1,696,445 | $-3,209,475 | $-4,754,152 |
| Interest Income | $371,444 | $142,488 | $46,935 | $45,179 |
| Normalized Income | $-136,790 | $-17,384,922 | $-25,428,348 | $-29,764,763 |
| Net Income From Continuing And Discontinued Operation | $11,992,780 | $-32,668,530 | $-37,283,233 | $-34,805,712 |
| Total Operating Income As Reported | $324,717 | $-30,748,655 | $-34,567,121 | $-23,273,036 |
| Average Dilution Earnings | $636,742 | $0 | - | - |
| Net Income Common Stockholders | $11,356,038 | $-32,668,530 | $-37,283,233 | $-41,972,464 |
| Net Income | $11,992,780 | $-32,668,530 | $-37,283,233 | $-34,805,712 |
| Net Income Including Noncontrolling Interests | $11,992,780 | $-32,668,530 | $-37,283,233 | $-34,805,712 |
| Net Income Continuous Operations | $11,992,780 | $-32,668,530 | $-37,283,233 | $-34,805,712 |
| Pretax Income | $12,169,442 | $-32,668,530 | $-37,283,233 | $-34,761,884 |
| Special Income Charges | $12,313,709 | $-15,060,178 | $-12,348,248 | $88,639 |
| Interest Income Non Operating | $371,444 | $142,488 | $46,935 | $45,179 |
| Operating Income | $399,855 | $-15,688,477 | $-22,218,873 | $-23,102,322 |
| Gross Profit | $5,162,938 | $-90,694 | $-816,698 | $1,457,583 |
| Per Share | ||||
| Diluted EPS | $2.30 | $-41.47 | $-152.70 | $-228.00 |
| Basic EPS | $2.44 | $-41.47 | $-152.70 | $-228.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $184,714 | $0 | $0 | $-1,864,461 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $37,486 | $-14,227,392 | $-20,529,157 | $-20,343,236 |
| Total Unusual Items | $12,314,284 | $-15,283,608 | $-11,854,885 | $-6,905,410 |
| Total Unusual Items Excluding Goodwill | $12,314,284 | $-15,283,608 | $-11,854,885 | $-6,905,410 |
| Reconciled Depreciation | $174,773 | $1,318,597 | $1,642,781 | $2,713,907 |
| EBITDA (Bullshit earnings) | $12,351,770 | $-29,511,000 | $-32,384,042 | $-27,248,646 |
| EBIT | $12,176,997 | $-30,829,597 | $-34,026,823 | $-29,962,553 |
| Diluted Average Shares | $5,219,902 | $787,832 | $244,158 | $183,370 |
| Basic Average Shares | $4,655,225 | $787,832 | $244,158 | $183,370 |
| Diluted NI Availto Com Stockholders | $11,992,780 | $-32,668,530 | $-37,283,233 | $-41,972,464 |
| Preferred Stock Dividends | $636,742 | - | - | - |
| Tax Provision | $176,662 | $0 | $0 | $43,828 |
| Gain On Sale Of Business | $-75,138 | $-12,979,061 | $0 | - |
| Other Special Charges | $-10,309,272 | - | - | $-259,353 |
| Impairment Of Capital Assets | $-2,079,575 | $2,081,117 | $12,348,248 | $170,714 |
| Gain On Sale Of Security | $575 | $-223,430 | $493,363 | $-6,994,049 |
| Research And Development | $48,820 | $4,732,851 | $8,173,435 | $10,910,679 |
| Selling General And Administration | $4,714,263 | $10,864,932 | $13,228,740 | $13,649,226 |
| Other Gand A | $4,542,025 | $8,081,664 | $8,884,084 | $9,935,963 |
| Otherunder Preferred Stock Dividend | - | - | $0 | $7,166,752 |
| Gain On Sale Of Ppe | - | - | - | $0 |
| Restructuring And Mergern Acquisition | - | - | - | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $7,380,628 | $-11,561,584 | $134,574 | $19,233,864 |
| Total Assets | $9,862,698 | $1,882,274 | $25,813,149 | $71,666,533 |
| Total Non Current Assets | $7,213,471 | $302,400 | $15,157,661 | $31,923,958 |
| Other Non Current Assets | $302,262 | $302,262 | $2,796,243 | $4,024,131 |
| Non Current Deferred Assets | $6,269 | $0 | - | - |
| Investmentin Financial Assets | $5,000,000 | $0 | - | - |
| Current Assets | $2,649,227 | $1,579,874 | $10,655,488 | $39,742,575 |
| Other Current Assets | $1,309,316 | $324,735 | $1,355,949 | $1,250,331 |
| Receivables | $29,258 | $103,316 | $514,372 | $1,172,396 |
| Accounts Receivable | $29,258 | $103,316 | $514,372 | $1,172,396 |
| Allowance For Doubtful Accounts Receivable | $0 | $0 | $0 | $0 |
| Gross Accounts Receivable | $29,258 | $103,316 | $514,372 | $1,172,396 |
| Cash Cash Equivalents And Short Term Investments | $1,310,653 | $1,151,823 | $7,440,030 | $36,080,392 |
| Cash And Cash Equivalents | $1,310,653 | $1,151,823 | $7,440,030 | $36,080,392 |
| Goodwill And Other Intangible Assets | - | $0 | $7,440,974 | $21,983,216 |
| Inventory | - | $0 | $1,345,137 | $1,239,456 |
| Other Intangible Assets | - | - | $7,440,974 | $14,530,209 |
| Prepaid Assets | - | - | - | $1,250,331 |
| Debt | ||||
| Total Debt | $2,111,893 | $13,043,706 | $14,821,995 | $25,179,352 |
| Long Term Debt And Capital Lease Obligation | $1,847,889 | $2,021,616 | $7,417,104 | $10,157,297 |
| Current Debt And Capital Lease Obligation | $264,004 | $11,022,090 | $7,404,891 | $15,022,055 |
| Current Debt | $90,278 | $10,873,867 | $7,023,901 | $14,519,113 |
| Other Current Borrowings | $90,278 | - | - | $14,519,113 |
| Net Debt | - | $9,722,044 | $4,434,557 | - |
| Long Term Debt | - | - | $4,850,686 | $7,176,251 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,482,070 | $13,443,858 | $18,237,601 | $30,449,453 |
| Total Non Current Liabilities Net Minority Interest | $1,847,889 | $2,021,616 | $7,645,970 | $10,532,684 |
| Current Liabilities | $634,181 | $11,422,242 | $10,591,631 | $19,916,769 |
| Current Deferred Liabilities | $0 | $25,926 | $142,061 | $0 |
| Current Notes Payable | $0 | $10,873,867 | $7,023,901 | $14,519,113 |
| Payables And Accrued Expenses | $307,270 | $246,625 | $1,947,025 | $3,272,926 |
| Payables | $245,196 | $111,149 | $420,821 | $1,307,081 |
| Accounts Payable | $245,196 | $111,149 | $420,821 | $1,307,081 |
| Derivative Product Liabilities | - | $0 | $99,498 | $228,589 |
| Other Non Current Liabilities | - | - | $129,368 | $146,798 |
| Equity | ||||
| Common Stock Equity | $7,380,626 | $-11,564,084 | $7,575,548 | $41,217,080 |
| Preferred Stock Equity | $2 | $2,500 | - | - |
| Total Equity Gross Minority Interest | $7,380,628 | $-11,561,584 | $7,575,548 | $41,217,080 |
| Stockholders Equity | $7,380,628 | $-11,561,584 | $7,575,548 | $41,217,080 |
| Gains Losses Not Affecting Retained Earnings | $0 | $-75,138 | $-795,840 | $585,626 |
| Retained Earnings | $-293,500,522 | $-305,493,302 | $-272,824,772 | $-235,541,539 |
| Other Equity Adjustments | - | $-75,138 | $-795,840 | $585,626 |
| Other | ||||
| Ordinary Shares Number | $10,070,779 | $1,282,686 | $289,991 | $232,251 |
| Share Issued | $10,070,779 | $1,282,686 | $289,991 | $232,251 |
| Tangible Book Value | $7,380,626 | $-11,564,084 | $134,574 | $19,233,864 |
| Invested Capital | $7,470,904 | $-690,217 | $19,450,135 | $62,912,444 |
| Working Capital | $2,015,046 | $-9,842,368 | $63,857 | $19,825,806 |
| Capital Lease Obligations | $2,021,615 | $2,169,839 | $2,947,408 | $3,483,988 |
| Total Capitalization | $7,380,628 | $-11,561,584 | $12,426,234 | $48,393,331 |
| Additional Paid In Capital | $300,780,440 | $293,991,529 | $281,193,260 | $276,149,768 |
| Capital Stock | $100,710 | $15,327 | $2,900 | $23,225 |
| Common Stock | $100,708 | $12,827 | $2,900 | $23,225 |
| Preferred Stock | $2 | $2,500 | $0 | $0 |
| Long Term Capital Lease Obligation | $1,847,889 | $2,021,616 | $2,566,418 | $2,981,046 |
| Current Deferred Revenue | $0 | $25,926 | $142,061 | $0 |
| Current Capital Lease Obligation | $173,726 | $148,223 | $380,990 | $502,942 |
| Pensionand Other Post Retirement Benefit Plans Current | $62,907 | $127,601 | $1,097,654 | $1,621,788 |
| Current Accrued Expenses | $62,074 | $135,476 | $1,526,204 | $1,965,845 |
| Investments And Advances | $5,000,000 | $0 | - | - |
| Available For Sale Securities | $5,000,000 | - | - | - |
| Net PPE | $1,904,940 | $138 | $4,920,444 | $5,916,611 |
| Accumulated Depreciation | $-1,615,906 | $-1,464,849 | $-4,061,280 | $-3,538,025 |
| Gross PPE | $3,520,846 | $1,464,987 | $8,981,724 | $9,454,636 |
| Leases | $1,627,998 | $397,666 | $1,667,302 | $1,634,692 |
| Other Properties | $1,439,701 | $614,174 | $6,175,581 | $6,518,187 |
| Machinery Furniture Equipment | $453,147 | $453,147 | $1,138,841 | $1,301,757 |
| Properties | $0 | $0 | $0 | $0 |
| Goodwill | - | - | $0 | $7,453,007 |
| Other Inventories | - | - | - | $-3,472,337 |
| Finished Goods | - | - | - | $3,744,029 |
| Work In Process | - | - | - | $100,801 |
| Raw Materials | - | - | - | $866,963 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,869,744 | $-15,119,954 | $-21,040,470 | $-23,462,891 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,869,744 | $-14,319,542 | $-20,449,698 | $-21,479,277 |
| Cash Flow From Continuing Operating Activities | $-4,869,744 | $-14,319,542 | $-20,449,698 | $-21,479,277 |
| Operating Gains Losses | $-495,647 | $12,925,090 | $-97,740 | $7,625,919 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $-800,412 | $-590,772 | $-1,983,614 |
| Cash Flow From Continuing Investing Activities | $0 | $-800,412 | $-590,772 | $-1,983,614 |
| Capital Expenditure | - | $-800,412 | $-590,772 | $-1,983,614 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $4,938,576 | $12,291,168 | $4,072,232 | $38,809,054 |
| Financing Cash Flow | $5,028,574 | $8,373,314 | $-6,735,681 | $47,451,431 |
| Cash Flow From Continuing Financing Activities | $5,028,574 | $8,373,314 | $-6,735,681 | $47,451,431 |
| Net Preferred Stock Issuance | $2,950,217 | $250,000 | $0 | $13,851,259 |
| Preferred Stock Issuance | $2,950,217 | $250,000 | $0 | $13,851,259 |
| Net Common Stock Issuance | $1,988,359 | $12,041,168 | $4,072,232 | $24,957,795 |
| Common Stock Issuance | $1,988,359 | $12,041,168 | $4,072,232 | $24,957,795 |
| Other | ||||
| Repayment Of Debt | $-210,928 | $-3,917,854 | $-10,807,913 | $-707,546 |
| Issuance Of Debt | $300,926 | $0 | - | $0 |
| Interest Paid Supplemental Data | $7,555 | $1,424,140 | $1,079,113 | $895,200 |
| End Cash Position | $1,612,915 | $1,454,085 | $7,935,659 | $36,632,186 |
| Beginning Cash Position | $1,454,085 | $7,935,659 | $36,632,186 | $14,107,255 |
| Effect Of Exchange Rate Changes | $0 | $265,066 | $-920,376 | $-1,463,609 |
| Changes In Cash | $158,830 | $-6,746,640 | $-27,776,151 | $23,988,540 |
| Net Issuance Payments Of Debt | $89,998 | $-3,917,854 | $-10,807,913 | $-707,546 |
| Net Short Term Debt Issuance | $90,278 | $-3,914,490 | $-10,764,763 | $-441,076 |
| Short Term Debt Payments | $-210,648 | $-3,914,490 | $-10,764,763 | $-441,076 |
| Short Term Debt Issuance | $300,926 | $0 | - | - |
| Net Long Term Debt Issuance | $-280 | $-3,364 | $-43,150 | $-266,470 |
| Long Term Debt Payments | $-280 | $-3,364 | $-43,150 | $-266,470 |
| Net PPE Purchase And Sale | $0 | $-800,412 | $-590,772 | $-1,983,614 |
| Purchase Of PPE | $0 | $-800,412 | $-590,772 | $-1,983,614 |
| Change In Working Capital | $-4,135,811 | $-1,034,606 | $-1,951,934 | $-2,051,435 |
| Change In Other Working Capital | $-25,926 | $74,109 | $139,570 | $-9,808 |
| Change In Other Current Assets | $-4,657,565 | $-259,173 | $151,456 | $739,429 |
| Change In Payables And Accrued Expense | $418,792 | $-1,637,102 | $-2,102,173 | $130,781 |
| Change In Accrued Expense | $284,745 | $-1,612,944 | $-1,287,874 | $602,605 |
| Change In Payable | $134,047 | $-24,158 | $-814,299 | $-471,824 |
| Change In Account Payable | $134,047 | $-24,158 | $-814,299 | $-471,824 |
| Change In Inventory | $54,830 | $748,445 | $-728,548 | $-2,336,714 |
| Change In Receivables | $74,058 | $39,115 | $587,761 | $-575,123 |
| Changes In Account Receivables | $74,058 | $39,115 | $587,761 | $-575,123 |
| Other Non Cash Items | $-10,873,867 | $2,024,976 | $2,359,219 | $3,988,755 |
| Stock Based Compensation | $602,433 | $235,974 | $950,935 | $878,575 |
| Provisionand Write Offof Assets | $-54,830 | $797,840 | $1,582,026 | - |
| Asset Impairment Charge | $-2,079,575 | $2,081,117 | $12,348,248 | $170,714 |
| Depreciation Amortization Depletion | $174,773 | $1,318,597 | $1,642,781 | $2,713,907 |
| Depreciation And Amortization | $174,773 | $1,318,597 | $1,642,781 | $2,713,907 |
| Pension And Employee Benefit Expense | $-570,785 | $0 | - | - |
| Gain Loss On Sale Of PPE | $0 | $10,288 | $16,000 | $0 |
| Gain Loss On Sale Of Business | $75,138 | $12,979,061 | $0 | - |
| Net Income From Continuing Operations | $11,992,780 | $-32,668,530 | $-37,283,233 | $-34,805,712 |
| Gain Loss On Investment Securities | - | $-64,259 | $-113,740 | $7,885,272 |
| Proceeds From Stock Option Exercised | - | - | $0 | $9,349,923 |
| Long Term Debt Issuance | - | - | - | $0 |
| Net Business Purchase And Sale | - | - | - | $0 |
| Sale Of Business | - | - | - | $0 |
Fetched: 2026-02-02